Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001415889-24-018441

Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kung Winston Director 2024-06-26 Grant or award +2,500 2,500 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kung Winston Director 2024-06-26 Grant or award · Stock Option (right to buy) +8,350 8,350 D: show line 2 in the form
Loading xslF345X05/form4-06282024_040641.xml…